IVF Hartmann Holding AG
SIX:VBSN
IVF Hartmann Holding AG
Cost of Revenue
IVF Hartmann Holding AG
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IVF Hartmann Holding AG
SIX:VBSN
|
Cost of Revenue
-CHf70m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
|
Alcon AG
SIX:ALC
|
Cost of Revenue
-$4.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Coltene Holding AG
SIX:CLTN
|
Cost of Revenue
-CHf95.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Medartis Holding AG
SIX:MED
|
Cost of Revenue
-CHf44.4m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Ypsomed Holding AG
SIX:YPSN
|
Cost of Revenue
-CHf359.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
See Also
What is IVF Hartmann Holding AG's Cost of Revenue?
Cost of Revenue
-70m
CHF
Based on the financial report for Dec 31, 2022, IVF Hartmann Holding AG's Cost of Revenue amounts to -70m CHF.
What is IVF Hartmann Holding AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-3%
Over the last year, the Cost of Revenue growth was 0%. The average annual Cost of Revenue growth rates for IVF Hartmann Holding AG have been -2% over the past three years , -5% over the past five years , and -3% over the past ten years .